Order Article Reprints

Song Z-Y, Kim M-H, Lee H-C, Park S-J, Rhee M-Y, Choi J-I, Kim S-H, Chae I-H, Hong Y-J, Lee N-H, et al. Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial. Journal of Clinical Medicine. 2023; 12(6):2377. https://doi.org/10.3390/jcm12062377

Song, Zhao-Yan, Moo-Hyun Kim, Han-Cheol Lee, Sung-Ji Park, Moo-Yong Rhee, Jong-Il Choi, Sang-Hyun Kim, In-Ho Chae, Young-Joon Hong, Nam-Ho Lee, and et al. 2023. "Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial" Journal of Clinical Medicine 12, no. 6: 2377. https://doi.org/10.3390/jcm12062377

Song, Z.-Y., Kim, M.-H., Lee, H.-C., Park, S.-J., Rhee, M.-Y., Choi, J.-I., Kim, S.-H., Chae, I.-H., Hong, Y.-J., Lee, N.-H., Hwang, G.-S., Hur, S.-H., Son, J.-W., Chae, J.-K., & Kim, H.-S. (2023). Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial. Journal of Clinical Medicine, 12(6), 2377. https://doi.org/10.3390/jcm12062377